Cofactor Genomics
Jarret Glasscock is the Chief Executive Officer of Cofactor Genomics Inc., an RNA diagnostics company. He has been with the company since January 2016.
Jarret Glasscock served as an Industry Advisory Board Member at SLU from Aug 2014 to Present. In this role, he advised on the direction and curriculum of the Bioinformatics and Computational Biology Degree Program.
Jarret Glasscock was the Founder and CTO at Cofactor Genomics LLC from Jan 2008 to Jan 2010. He was focused on providing direction and expertise to Cofactor concerning its goals of visualization and algorithmic approaches necessary to keep pace with its Next Generation Sequencing Services. Specific applications for genomic, miRNA, epigenitic, and transcriptome studies were his focus while at Cofactor Genomics LLC.
The people who report to Jarret Glasscock at Cofactor Genomics Inc. are Dave Messina, Natalie LaFranzo, Eric Duncavage, and Sara Lapomarda.
Cofactor Genomics
Cofactor Genomics is bridging the precision medicine gap by building diagnostic tools to match the right patient to the right treatment at the right time. Predicting patient response currently relies on isolated, single-analyte biomarkers that have failed to deliver accurate therapy response predictions, resulting in unnecessary healthcare costs, and most harmfully, negative outcomes for patients. Cofactor’s products use Predictive Immune Modeling, which leverages RNA data and machine learning to combine biological signals, creating multidimensional biomarkers to deliver on the promise of precision medicine. Cofactor Genomics offers its full-service molecular, informatic, and database tools to make drug discovery, clinical trials and therapy selection more successful.